Bone metastasis after stage IIIA non-small cell lung cancer: risks and prognosis

Bessa, Camila Martins de; Silva, Larissy Machado da; Zamboni, Mauro Musa; Costa, Guilherme Jorge; Bergmann, Anke; Thuler, Luiz Claudio Santos; Silva, Gustavo Telles da.
J. bras. pneumol ; 48(5): e20220211, 2022. tab
Artigo em Inglês | LILACS-Express | ID: biblio-1405429

Documentos relacionados

  1. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
  2. [Lung cancer: is surgery an option for persisting N2 after induction therapy?].
  3. [T4 lung cancer: results of surgical treatment].
  4. [Non-surgical biopsy in lung cancer: a paradigm shift].
  5. Metastatic extent-specific prognosis of women with stage IVB cervical cancer: multiple versus single distant organ involvement.
  6. [Adrenocortical cancer: morphological variants, immunohistochemical characteristics].
  7. Lung Cancer: A Wily Genetic Opponent.
  8. [Lung Resection after Definitive and Neo-Adjuvant Chemoradiation for Stage IIIA/B Locally Advanced Non-Small Cell Lung Cancer: a Retrospective Analysis].
  9. [Anatomical resection for non-small cell lung cancer: cardiopulmonary exercise testing in assessing the risk of respiratory complications].
  10. [When to Test in Biomarker-stratified Therapy of Non-small Cell Lung Cancer - Biomarker-stratified Therapy of Non-small Cell Lung Cancer: When and What to Test?]